Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11
|
1 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 0 | ||||||||
Lupus Erythematosus
|
44 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Lupus Vulgaris
|
44 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Diabetes
|
710 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2009 | 2009 | ||||||
Diabetes Mellitus
|
824 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2009 | 2009 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2009 | 2009 | ||||||
Giant Cell Arteritis
|
78 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2009 | 2009 | ||||||
Hematological Disease
|
16 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Psoriasis
|
705 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2009 | 2010 | |||||
Behcet Syndrome
|
243 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Crohn's disease of large bowel
|
1 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Uveomeningoencephalitic Syndrome
|
27 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Alveolitis, Fibrosing
|
4 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Hamman-Rich syndrome
|
8 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Idiopathic Pulmonary Fibrosis
|
63 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Immune System Diseases
|
116 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Multiple Sclerosis
|
1022 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Polyendocrinopathies, Autoimmune
|
21 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 0.500 | 2 | 2009 | 2012 | |||||
Arthritis
|
69 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Biliary cirrhosis
|
36 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Drug-Induced Liver Disease
|
29 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Primary Sjögren's syndrome
|
42 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.030 | 0.667 | 3 | 2010 | 2013 | |||||
Hepatitis C
|
347 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.020 | 1.000 | 2 | 2013 | 2013 | |||||
Ankylosing spondylitis
|
609 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1 | 2013 | 2013 | ||||||
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
|
3 | 0.574 | 0.720 | 2 | 191099907 | intron variant | T/G | snv | 0.79 | 0.010 | 1.000 | 1 | 2013 | 2013 |